DK45590D0 - - Google Patents

Info

Publication number
DK45590D0
DK45590D0 DK045590A DK45590A DK45590D0 DK 45590 D0 DK45590 D0 DK 45590D0 DK 045590 A DK045590 A DK 045590A DK 45590 A DK45590 A DK 45590A DK 45590 D0 DK45590 D0 DK 45590D0
Authority
DK
Denmark
Application number
DK045590A
Other languages
Danish (da)
Inventor
Joergen Frederik Hansen
Ulla Ribel-Madsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK045590A priority Critical patent/DK45590D0/da
Publication of DK45590D0 publication Critical patent/DK45590D0/da
Priority to IE057991A priority patent/IE910579A1/en
Priority to NZ237176A priority patent/NZ237176A/en
Priority to ZA911279A priority patent/ZA911279B/xx
Priority to DE91904980T priority patent/DE69100626D1/de
Priority to HU922721Q priority patent/HUT63858A/hu
Priority to AU73378/91A priority patent/AU641991B2/en
Priority to AT91904980T priority patent/ATE97002T1/de
Priority to EP91904980A priority patent/EP0516704B1/en
Priority to MX9203359A priority patent/MX9203359A/es
Priority to PT96841A priority patent/PT96841A/pt
Priority to PCT/DK1991/000052 priority patent/WO1991012817A1/en
Priority to CA002075982A priority patent/CA2075982A1/en
Priority to JP3504590A priority patent/JPH05503940A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Chairs For Special Purposes, Such As Reclining Chairs (AREA)
DK045590A 1990-02-21 1990-02-21 DK45590D0 (en:Method)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DK045590A DK45590D0 (en:Method) 1990-02-21 1990-02-21
IE057991A IE910579A1 (en) 1990-02-21 1991-02-20 Novel protein compositions
NZ237176A NZ237176A (en) 1990-02-21 1991-02-20 Insulin cobalt iii complex compositions
JP3504590A JPH05503940A (ja) 1990-02-21 1991-02-21 新規インスリン組成物
AU73378/91A AU641991B2 (en) 1990-02-21 1991-02-21 Novel insulin compositions
DE91904980T DE69100626D1 (de) 1990-02-21 1991-02-21 Neue zusammensetzungen auf insulinbasis.
HU922721Q HUT63858A (en) 1990-02-21 1991-02-21 Process for producing new insulin complexes
ZA911279A ZA911279B (en) 1990-02-21 1991-02-21 Novel protein compositions
AT91904980T ATE97002T1 (de) 1990-02-21 1991-02-21 Neue zusammensetzungen auf insulinbasis.
EP91904980A EP0516704B1 (en) 1990-02-21 1991-02-21 Novel insulin compositions
MX9203359A MX9203359A (es) 1990-02-21 1991-02-21 Nuevas composiciones farmaceuticas de insulina.
PT96841A PT96841A (pt) 1990-02-21 1991-02-21 Processo para a preparacao de composicoes farmaceuticas de insulina contendo novos complexos insulinicos de co(iii)
PCT/DK1991/000052 WO1991012817A1 (en) 1990-02-21 1991-02-21 Novel insulin compositions
CA002075982A CA2075982A1 (en) 1990-02-21 1991-02-21 Insulin compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK045590A DK45590D0 (en:Method) 1990-02-21 1990-02-21

Publications (1)

Publication Number Publication Date
DK45590D0 true DK45590D0 (en:Method) 1990-02-21

Family

ID=8093754

Family Applications (1)

Application Number Title Priority Date Filing Date
DK045590A DK45590D0 (en:Method) 1990-02-21 1990-02-21

Country Status (12)

Country Link
EP (1) EP0516704B1 (en:Method)
JP (1) JPH05503940A (en:Method)
AU (1) AU641991B2 (en:Method)
CA (1) CA2075982A1 (en:Method)
DE (1) DE69100626D1 (en:Method)
DK (1) DK45590D0 (en:Method)
HU (1) HUT63858A (en:Method)
IE (1) IE910579A1 (en:Method)
NZ (1) NZ237176A (en:Method)
PT (1) PT96841A (en:Method)
WO (1) WO1991012817A1 (en:Method)
ZA (1) ZA911279B (en:Method)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9316895D0 (en) * 1993-08-13 1993-09-29 Guy S And St Thomas Hospitals Hepatoselective insulin analogues
US6342225B1 (en) 1993-08-13 2002-01-29 Deutshces Wollforschungsinstitut Pharmaceutical active conjugates
US6011007A (en) * 1993-09-17 2000-01-04 Novo Nordisk A/S Acylated insulin
US6869930B1 (en) 1993-09-17 2005-03-22 Novo Nordisk A/S Acylated insulin
EP1132404A3 (en) * 1993-09-17 2002-03-27 Novo Nordisk A/S Acylated insulin
US6251856B1 (en) 1995-03-17 2001-06-26 Novo Nordisk A/S Insulin derivatives
US6451762B1 (en) 1997-10-24 2002-09-17 Novo Nordisk A/S Aggregates of human insulin derivatives
KR101159559B1 (ko) 2003-08-05 2012-06-26 노보 노르디스크 에이/에스 신규의 인슐린 유도체
KR101186851B1 (ko) 2003-08-05 2012-10-02 노보 노르디스크 에이/에스 신규의 인슐린 유도체
JP4933455B2 (ja) 2005-02-02 2012-05-16 ノヴォ ノルディスク アー／エス 新規のインスリン誘導体
PT1969004E (pt) 2005-12-28 2011-11-25 Novo Nordisk As Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
WO2008015099A2 (en) 2006-07-31 2008-02-07 Novo Nordisk A/S Pegylated, extended insulins
WO2008034881A1 (en) 2006-09-22 2008-03-27 Novo Nordisk A/S Protease resistant insulin analogues
JP5496082B2 (ja) 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー／エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
WO2008152106A1 (en) 2007-06-13 2008-12-18 Novo Nordisk A/S Pharmaceutical formulation comprising an insulin derivative
JP5762001B2 (ja) 2008-03-14 2015-08-12 ノボ・ノルデイスク・エー／エス プロテアーゼ安定化インスリンアナログ
RU2571857C2 (ru) 2008-03-18 2015-12-20 Ново Нордиск А/С Стабилизированные по отношению к протеазам ацилированные аналоги инсулина
US9603904B2 (en) 2008-10-30 2017-03-28 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency
BR112013010345A2 (pt) 2010-10-27 2017-07-25 Novo Nordisk As tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
JP6199956B2 (ja) 2012-04-11 2017-09-20 ノヴォ ノルディスク アー／エス インスリン製剤
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
SI3055325T1 (en) 2013-10-07 2018-05-31 Novo Nordisk A/S NEW DERIVATIVE ANALOGUE INSULINE
EP3554534B1 (en) 2016-12-16 2021-06-23 Novo Nordisk A/S Insulin containing pharmaceutical compositions
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
JP7518149B2 (ja) 2019-07-12 2024-07-17 ノヴォ ノルディスク アー／エス 高濃度インスリン製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE971500C (de) * 1950-11-22 1959-02-05 Organon Nv Verfahren zur Herstellung von Insulin-Suspensionen mit verlaengerter Wirkung
DE1107374B (de) * 1958-01-31 1961-05-25 Organon Nv Verfahren zur Herstellung eines Insulin-Praeparates

Also Published As

Publication number Publication date
IE910579A1 (en) 1991-08-28
AU641991B2 (en) 1993-10-07
HUT63858A (en) 1993-10-28
HU9202721D0 (en) 1992-12-28
AU7337891A (en) 1991-09-18
EP0516704A1 (en) 1992-12-09
JPH05503940A (ja) 1993-06-24
WO1991012817A1 (en) 1991-09-05
ZA911279B (en) 1991-10-30
DE69100626D1 (de) 1993-12-16
PT96841A (pt) 1991-11-29
EP0516704B1 (en) 1993-11-10
NZ237176A (en) 1991-12-23
CA2075982A1 (en) 1991-08-22

Similar Documents

Publication Publication Date Title
EP0440166A3 (en:Method)
DK45590D0 (en:Method)
DE4190102T (en:Method)
DE4190090T (en:Method)
FR2665458B1 (en:Method)
IT9020799A0 (en:Method)
JPH0492783U (en:Method)
DE4092472T (en:Method)
JPH0490918U (en:Method)
FR2657664B1 (en:Method)
AU7272091A (en:Method)
JPH0430915U (en:Method)
ECSM90486U (en:Method)
ECSM90451U (en:Method)
ECSM90520U (en:Method)
IN178750B (en:Method)
ECSM90398U (en:Method)
IN179337B (en:Method)
ECSM90481U (en:Method)
EP0473265A3 (en:Method)
EP0448034A3 (en:Method)
EP0480410A3 (en:Method)
EP0475403A3 (en:Method)
EP0473454A3 (en:Method)
EP0482215A4 (en:Method)

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment